Listed

Mesa Laboratories Inc: Form 10-Q for the period ended Dec 31, 2018

Filed with the SEC on Feb 4, 2019 and accepted by EDGAR at Feb 4, 2019, 08:02 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2018-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cost of revenue3 months2018-10-01 to 2018-12-31$11.0mus-gaap:CostOfRevenue
Cost of revenue9 months2018-04-01 to 2018-12-31$31.4mus-gaap:CostOfRevenue
Gross profit3 months2018-10-01 to 2018-12-31$15.6mus-gaap:GrossProfit
Gross profit9 months2018-04-01 to 2018-12-31$45.3mus-gaap:GrossProfit
Research and development3 months2018-10-01 to 2018-12-31$860.0kus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2018-04-01 to 2018-12-31$2.5mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2018-10-01 to 2018-12-31$1.3mus-gaap:OperatingIncomeLoss
Operating income9 months2018-04-01 to 2018-12-31$7.2mus-gaap:OperatingIncomeLoss
Income tax3 months2018-10-01 to 2018-12-31$90.0kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2018-04-01 to 2018-12-31$572.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2018-10-01 to 2018-12-31$858.0kus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Net income9 months2018-04-01 to 2018-12-31$6.1mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Diluted EPS3 months2018-10-01 to 2018-12-31$0.21us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2018-04-01 to 2018-12-31$1.51us-gaap:EarningsPerShareDiluted
Basic EPS3 months2018-10-01 to 2018-12-31$0.22us-gaap:EarningsPerShareBasic
Basic EPS9 months2018-04-01 to 2018-12-31$1.58us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2018-10-01 to 2018-12-314,045,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2018-04-01 to 2018-12-314,037,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2018-04-01 to 2018-12-31$20.3mus-gaap:NetCashProvidedByUsedInOperatingActivities
Dividends paid9 months2018-04-01 to 2018-12-31$1.8mus-gaap:PaymentsOfDividends
Cash and equivalentsAt period end2018-12-31$5.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2018-12-31$32.6mus-gaap:AssetsCurrent
Total assetsAt period end2018-12-31$158.2mus-gaap:Assets
Current liabilitiesAt period end2018-12-31$20.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2018-12-31$50.6mus-gaap:Liabilities
Long-term debtAt period end2018-12-31$27.2mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2018-12-31$2.0mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2018-12-31$107.6mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001437749-19-001738. Last ingested by Listed: Nov 13, 2026, 07:45 ET. Listed shows no prices and gives no investment advice.